Literature DB >> 11001172

Roles of prostanoids revealed from studies using mice lacking specific prostanoid receptors.

F Ushikubi1, Y Sugimoto, A Ichikawa, S Narumiya.   

Abstract

The actions of prostanoids in various physiological and pathophysiological conditions have been being examined using mice lacking different prostanoid receptors. Prostaglandin (PG) I2 worked not only as a mediator of inflammation but also as an antithrombotic agent. PGF2alpha was found to be an essential inducer of labor. Several important actions of PGE2 are exerted via each of the four PGE2 receptor subtypes: EP1, EP2, EP3 and EP4. PGE2 participated in colon carcinogenesis via the EP1. PGE2 also participates in ovulation and fertilization and contributes to the control of blood pressure under high-salt intake via the EP2. PGE2 worked as a mediator of febrile responses to both endogenous and exogenous pyrogens and as a regulator of bicarbonate secretion induced by acid-stimulation in the duodenum via the EP3. It regulated the closure of ductus arteriosus and showed bone resorbing action via the EP4. PGD2 was found to be a mediator of allergic asthma. These studies have revealed important roles of prostanoids, some of which had not previously been known.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11001172     DOI: 10.1254/jjp.83.279

Source DB:  PubMed          Journal:  Jpn J Pharmacol        ISSN: 0021-5198


  10 in total

1.  Differential regulation of the aggressive phenotype of inflammatory breast cancer cells by prostanoid receptors EP3 and EP4.

Authors:  Fredika M Robertson; Ann-Marie Simeone; Anthony Lucci; John S McMurray; Sukhen Ghosh; Massimo Cristofanilli
Journal:  Cancer       Date:  2010-06-01       Impact factor: 6.860

2.  Prostaglandin E2 (EP) receptors mediate PGE2-specific events in ovulation and luteinization within primate ovarian follicles.

Authors:  Soon Ok Kim; Siabhon M Harris; Diane M Duffy
Journal:  Endocrinology       Date:  2014-02-07       Impact factor: 4.736

3.  The growth of malignant keratinocytes depends on signaling through the PGE(2) receptor EP1.

Authors:  E J Thompson; A Gupta; G A Vielhauer; J W Regan; G T Bowden
Journal:  Neoplasia       Date:  2001 Sep-Oct       Impact factor: 5.715

4.  Determination of prostaglandin profiles in lipopolysaccharide-challenged guinea pig spleen.

Authors:  X Yao; Y Dai; A Johnson; M A Hass; C Feleder
Journal:  Biomed Chromatogr       Date:  2012-09-12       Impact factor: 1.902

Review 5.  Transcriptional profiling of the ductus arteriosus: Comparison of rodent microarrays and human RNA sequencing.

Authors:  Michael T Yarboro; Matthew D Durbin; Jennifer L Herington; Elaine L Shelton; Tao Zhang; Cris G Ebby; Jason Z Stoller; Ronald I Clyman; Jeff Reese
Journal:  Semin Perinatol       Date:  2018-05-10       Impact factor: 3.300

Review 6.  mPGES-1 as a target for cancer suppression: A comprehensive invited review "Phospholipase A2 and lipid mediators".

Authors:  Masako Nakanishi; Vijay Gokhale; Emmanuelle J Meuillet; Daniel W Rosenberg
Journal:  Biochimie       Date:  2010-02-13       Impact factor: 4.079

7.  PGE2 EP1 receptor deletion attenuates 6-OHDA-induced Parkinsonism in mice: old switch, new target.

Authors:  Abdullah Shafique Ahmad; Takayuki Maruyama; Shuh Narumiya; Sylvain Doré
Journal:  Neurotox Res       Date:  2013-02-06       Impact factor: 3.911

8.  Neutrophils and the kallikrein-kinin system in proteinase-activated receptor 4-mediated inflammation in rodents.

Authors:  Steeve Houle; Martin D Papez; Mara Ferazzini; Morley D Hollenberg; Nathalie Vergnolle
Journal:  Br J Pharmacol       Date:  2005-11       Impact factor: 8.739

Review 9.  Prostaglandin E2 and T cells: friends or foes?

Authors:  Vinatha Sreeramkumar; Manuel Fresno; Natalia Cuesta
Journal:  Immunol Cell Biol       Date:  2011-09-27       Impact factor: 5.126

Review 10.  Present State and Future Perspectives of Prostaglandins as a Differentiation Factor in Motor Neurons.

Authors:  Hiroshi Nango; Yasuhiro Kosuge
Journal:  Cell Mol Neurobiol       Date:  2021-05-25       Impact factor: 4.231

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.